Benchmark Electronics, Inc. — Q3 2021 Form 10-Q
Reporting period: Quarter and nine months ended September 30, 2021. Benchmark provides product design, engineering, technology and advanced manufacturing services across aerospace and defense, medical, industrial, semiconductor capital equipment, computing and telecommunications markets. Amounts below are in U.S. dollars; financial statement figures are in millions unless noted.
Financial performance and liquidity
| Metric | Q3 2021 | Q3 2020 | 9M 2021 | 9M 2020 |
|---|---|---|---|---|
| Sales | $571.9 | $526.0 | $1,622.3 | $1,531.9 |
| Gross profit / margin | $53.7 / 9.4% | $46.4 / 8.8% | $143.8 / 8.9% | $124.4 / 8.1% |
| Operating income / margin | $11.8 / 2.1% | $8.7 / 1.6% | $34.4 / 2.1% | $13.3 / 0.9% |
| Net income | $8.1 | $5.9 | $23.4 | $6.4 |
| Diluted EPS | $0.23 | $0.16 | $0.64 | $0.17 |
| Operating cash flow | Not provided separately | Not provided separately | $(1.3) | $25.6 |
- For the first nine months, capital expenditures were $29.5 million; investing cash outflow was $32.1 million. Financing cash outflow was $66.9 million, including $40.2 million of share repurchases and $17.4 million of dividends.
- At September 30, cash and cash equivalents were $288.6 million, with restricted cash of $2.6 million. Working capital was approximately $0.7 billion.
- Debt consisted of $131.3 million outstanding on the term loan, reported net of issuance costs at $130.4 million; $7.7 million of current debt installments were shown on the balance sheet. The company reported $496.1 million available on its revolving facility, subject to covenants, and compliance with covenants at quarter-end.
- Inventory rose to $478.3 million from $327.4 million at year-end 2020. Operating cash flow was weighed down chiefly by the $151.5 million inventory increase, partly offset by higher accounts payable.
Changes versus the prior comparable periods
- Q3 sales increased 9% year over year; nine-month sales rose 6%. Gross margin improved by 0.6 percentage points in Q3 and 0.8 points for the nine-month period.
- Q3 market-sector sales increased in industrials (26%), semiconductor capital equipment (35%) and computing (28%); they declined in aerospace and defense (4%), medical (12%) and telecommunications (5%). Management attributed medical weakness partly to lower COVID-related program demand and supply constraints; semiconductor equipment growth reflected strong demand.
- For the first nine months, operating income increased to $34.4 million from $13.3 million and net income to $23.4 million from $6.4 million. Management cited higher revenue and gross profit, lower restructuring costs and lower amortization, among other items.
- Americas sales declined about 2% over nine months, while Asia and Europe sales increased. Sales to the ten largest customers accounted for 47% of nine-month sales, compared with 42% a year earlier.
Outlook, commentary and risks
- Management said customer demand was recovering and highlighted ongoing, broad component shortages, longer lead times, supplier allocations and order pushouts. These disruptions constrained production against customer forecasts, caused operational inefficiencies and contributed to higher inventory days.
- The filing discusses forward-looking statements, including Q4 2021 guidance, but the supplied filing text does not provide a clear numeric Q4 guidance value. Management forecast capital expenditures of approximately $50–$60 million over the next 12 months, mainly for machinery and equipment, and said existing cash and expected operating funds should meet liquidity needs over that period.
- COVID-19 and the Delta variant, supply-chain and labor disruptions, component cost increases, customer concentration, and the possibility of delayed shipments or margin pressure are material risks. Management cautioned that pandemic effects and related economic conditions remain uncertain.
- Q3 restructuring and other costs were $6.4 million; the nine-month expense was $9.6 million, including $5.2 million of restructuring and other costs and $4.4 million of asset impairments. The company continued facility and workforce realignment efforts.
- The company collected $3.9 million of ransomware-related insurance recoveries during the first nine months of 2021; cumulative recoveries were $10.5 million, and no further recoveries were expected. These recoveries reduced reported incident costs.
- The Malaysia tax holiday expired April 1, 2021; the company applied for a new one, with no assurance of approval. A $7.3 million benefit for prior-year foreign withholding taxes was offset by a reserve for uncertain tax benefits. Total uncertain tax benefit reserves, including interest and penalties, were $8.0 million.
- Management said ordinary-course legal matters were not expected to have a material adverse effect. The company reported effective disclosure controls and no material change in internal control over financial reporting during the quarter.
Investor verification checklist
- Track whether component availability improves and whether the substantial inventory build converts into shipments and operating cash flow.
- Check subsequent filings or company releases for specific Q4 guidance and whether the $50–$60 million capital expenditure outlook changes.
- Monitor sales concentration, sector trends—particularly medical, aerospace and defense, and semiconductor capital equipment—and customer demand.
- Review the status of Malaysia tax incentives and the uncertain tax position, including any effect on the effective tax rate.
- Confirm debt covenant headroom and the sustainability of dividends and repurchases given negative nine-month operating cash flow.